CoChat

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

Abstract

Background The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics and beta blockers used. For a given reduction in blood pressure, some suggested that newer agents would confer advantages over diuretics and beta blockers. Our aim, therefore, was to compare the effect on non-fatal myocardial infarction and fatal CHD of combinations of atenolol with a thiazide versus amlodipine with perindopril. Methods We did a multicentre, prospective, randomised controlled trial in 19 257 patients with hypertension who were aged 40-79 years and had at least three other cardiovascular risk factors. Patients were assigned either amlodipine 5-10 mg adding perindopril 4-8 mg as required (amlodipine-based regimen; n=9639) or atenolol 50-100 mg adding bendroflumethiazide 1.25-2.5 mg and potassium as required (atenolol-based regimen; n=9618). Our primary endpoint was non-fatal myocardial infarction (including silent myocardial infarction) and fatal CHD. Analysis was by intention to treat. Findings The study was stopped prematurely after 5.5 years' median follow-up and accumulated in total 106 153 patient-years of observation. Though not significant, compared with the atenolol-based regimen, fewer individuals on the amlodipine-based regimen had a primary endpoint (429 vs 474; unadjusted HR 0.90, 95% CI 0.79-1.02, p=0.1052), fatal and non-fatal stroke (327 vs 422; 0.77, 0.66-0.89, p=0.0003), total c…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(05)67185-1

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 1

  1. Neaton, 1993, Treatment of mild hypertension study: final results, JAMA, 270, 713, 10.1001/jama.1993.03510060059034 · DOI · Paper page

Cited by

See all 2,909

Metadata

Authors
Dahlöf, B., Sever, P. S., Poulter, N. R., Wedel, H., Beevers, D. G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., Mehlsen, J., Nieminen, M., O'Brien, E., & Östergren, J.
Affiliations
  • Sahlgrenska University Hospital (SE)
  • Imperial College London (GB)
  • Nordic School of Public Health (SE)
  • Birmingham City Hospital (GB)
  • Queen Mary University of London (GB)
  • University of Oxford (GB)
  • University of Michigan (US)
  • University of Glasgow (GB)
  • Frederiksberg Hospital (DK)
  • Helsinki University Hospital (FI)
  • Royal College of Surgeons in Ireland (IE)
  • Karolinska University Hospital (SE)
Corresponding author
Dahlöf, Björn
Venue
The Lancet
Publisher
Elsevier BV
Published
2005-09
Volume
366
Issue
9489
Pages
895-906
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2129991662
Cited by
2,909
References
37
Citations by year
2026: 32 · 2025: 47 · 2024: 64 · 2023: 57 · 2022: 72 · 2021: 71 · 2020: 69 · 2019: 70 · 2018: 86 · 2017: 132 · 2016: 129 · 2015: 123 · 2014: 156 · 2013: 161 · 2012: 183
FWCI
184.81
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
  • Sahlgrenska Universitetssjukhuset
  • Servier
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
hypertension, cardiovascular event prevention, amlodipine, perindopril, atenolol, bendroflumethiazide, calcium channel blockers, ACE inhibitors, beta-blockers, thiazide diuretics, combination antihypertensive therapy, myocardial infarction, coronary artery disease, stroke, all-cause mortality, blood pressure reduction, ASCOT
MeSH terms
Adrenergic beta-Antagonists, Adult, Aged, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Atenolol, Bendroflumethiazide, Blood Pressure, Calcium Channel Blockers, Cardiovascular Diseases, Coronary Disease, Diuretics, Drug Therapy, Combination, Female, Humans, Hypertension, Male, Middle Aged, Risk Factors, Amlodipine, Perindopril, Sodium Chloride Symporter Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(05)67185-1
The paper
Dahlöf, B., Sever, P. S., Poulter, N. R., Wedel, H., Beevers, D. G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., Mehlsen, J., Nieminen, M., O'Brien, E., & Östergren, J. (2005). Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(05)67185-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.